According to Xinhua Pharmaceutical's announcement, the company's board of directors received the written resignation report submitted by He Tongqing on November 10, 2026. He Tongqing applied to resign as the company's chairman, director, members of various special committees under the board of directors, and all positions in the company's subsidiaries due to job changes. He did not hold positions as a director or executive in the company or subsidiary after his resignation. As of the disclosure date, He Tongqing held 503,200 A-shares of the company. On the same day, the company held the third interim meeting of the 11th board of directors in 2026 to deliberate and approve the election of Liu Weimin as the chairman of the 11th board of directors of the company.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.